States and Lidoderm

Seven years after the Federal Trade Commission launched its antitrust suit over the delay to market of a generic version of the Lidoderm painkiller patch – and nearly a year after <a href="https://www.courthousenews.com/270m-lidoderm-antitrust-settlements-finalized/">settling</a> the suit for $270 million – 18 states <strong><a href="http://www.courthousenews.com/wp-content/uploads/2019/07/LidodermStates-COMPLAINT.pdf">sued</a></strong> Endo Pharmaceutical on Friday over the issue.

SAN FRANCISCO – Seven years after the Federal Trade Commission launched its antitrust suit over the delay to market of a generic version of the Lidoderm painkiller patch – and nearly a year after settling the suit for $270 million – 18 states sued Endo Pharmaceutical on Friday over the issue.

Categories / Business, Health

Subscribe to our free newsletters

Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.